Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β-catenin and increases irinotecan sensitivity in colorectal cancer

With >1.85 million cases and 850,000 deaths annually, colorectal cancer (CRC) is the third most common cancer detected globally. CRC is an aggressive malignancy with metastasis and, in spite of advances in improved treatment regimen, distant disease failure rates remain disappointingly high. Muci...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Maha, Traiki, Thamer Bin, Vaali-Mohammed, Mansoor-Ali, El-Wetidy, Mohammad S., Alhassan, Noura, Al-Khayal, Khayal, Zubaidi, Ahmed, Al-Obeed, Omar, Ahmad, Rehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857929/
https://www.ncbi.nlm.nih.gov/pubmed/35059735
http://dx.doi.org/10.3892/ijo.2022.5312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857929/
https://www.ncbi.nlm.nih.gov/pubmed/35059735
http://dx.doi.org/10.3892/ijo.2022.5312

Ejemplares similares